Measuring the impact of the global response to the AIDS epidemic: Challenges and future directions

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue SUPPL. 2, 2009, Pages

  Mahy, Mary ^a   Warner Smith, Matthew ^a   Stanecki, Karen A ^a   Ghys, Peter D ^a  

^a UNAIDS   (Switzerland)

Author keywords

AIDS; Attribution; Estimates; Evaluation; HIV; Impact; Incidence; Modeling; Mortality; Prevalence

Indexed keywords

ADULT; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PUBLIC HEALTH; REVIEW; THEORETICAL MODEL; UNITED NATIONS; VERTICAL TRANSMISSION;

ADULT; HIV INFECTIONS; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MODELS, THEORETICAL; NATIONAL HEALTH PROGRAMS; UNITED NATIONS; WORLD HEALTH;

EID: 73349093468     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181baf128     Document Type: Article

References (47)

1. Brinkhof MWG, Boulle A, Weigel R, et al. Mortality of HIV-infected patients starting antiretroviral therapy in Sub-Saharan Africa: comparison with HIV unrelated mortality. PLoS Med. 6(4): e1000066. doi:10.1371/journal.pmed. 1000066.
2. The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.
3. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987-991. (Pubitemid 26340754)
4. Drucker E, Lurie P,Wodak A, et al. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS. 1998;12(Suppl A):S217-S230.
5. Hartgers C, Buning E, van Santen G, et al. The impact of the needle and syringe-exchange programme in Amsterdam in injecting risk behaviour. AIDS. 1989;3:571-576. (Pubitemid 19241047)
6. Lurie P, Sorensen J, Lane S, et al. The public health impact of needle exchange programs (NEPS). Int Conf AIDS. 1994;10:72.
7. United Nations. Declaration of Commitment on HIV/AIDS. New York, USA: United Nations; 2001.
8. EuroHIV. HIV/AIDS Surveillance in Europe. End-year report 2006. Saint-Maurice, France: Institut de veille sanitaire; 2007. No. 75.
9. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2007. vol 19. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. Available at: http://www.cdc.gov/hiv/ topics/surveillance/resources/reports/. Accessed October 2, 2009.
10. Hargrove JW,Humphrey JH,MutasaK, et al. ImprovedHIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS. 2008;22:511-518.
11. Zaba B, Boerma T, White R. Monitoring the AIDS epidemic using HIV prevalence data among young women attending antenatal clinics: prospects and problems. AIDS. 2000;14:1633-1645.
12. Hallett TB, Zaba B, Todd J, et al, on behalf of the ALPHA Network. Estimating incidence from prevalence in generalized HIV epidemics: methods and validation. PLoS Med. 2008;5(4):e80.
13. UNAIDS. Monitoring the Declaration of Commitment on HIV/AIDS: guidelines on construction of core indicators: 2010 reporting. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2009.
14. Lyerla RL, Gouws E, Garcia-Calleja JM. The quality of sero-surveillance in low-and middle-income countries: status and trends through 2007. Sex Transm Infect. 2008;84(Suppl I):i85-i91.
15. WHO. Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector: Progress Report 2008. Geneva, Switzerland: World Health Organization; 2008.
16. UNAIDS. 2008 Report on the Global AIDS Epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2009.
17. Brown T, Salomon JA, Alkema L, et al. Progress and challenges in modelling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007. Sex Transm Infect. 2008;84(Suppl 1): i5-i10.
18. Lyerla R, Gouws E, Garcia-Calleja JM, et al. The 2005 Workbook: an improved tool for estimating HIV prevalence in countries with low level and concentrated epidemics. Sex Transm Infect. 2006;82(Suppl 3): iii41-iii44. (Pubitemid 43901610)
19. Stover J, Johnson P, Zaba B, et al. The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect. 2008;84(Suppl 1):i24-i30.
20. Todd J, Glynn JR, Marston M, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middleincome countries before highly active antiretroviral therapy. AIDS. 2007; 21(Suppl 6):S55-S63. (Pubitemid 350158889)
21. Brown T, Peerapatanapokin W. The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia. Sex Transm Infect. 2004;80(Suppl I):i19-i24. (Pubitemid 39070780)
22. Dorrington RE, Bradshaw D, Johnson L, et al. The Demographic Impact of HIV/AIDS in South Africa: National and Provincial Indicators for 2006. Joint publication by the Centre for Actuarial Research, the Burden of Disease Research Unit (Medical Research Council) and the Actuarial Society of South Africa. 2006. Available at: http://aids.actuarialsociety.org.za/Models-3145.htm. Accessed October 2, 2009.
23. UNAIDS. 2006 AIDS Epidemic Update. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2006.
24. Gouws E, Stanecki KA, Lyerla R, et al. The epidemiology of HIV infection among young people aged 15-24 years in southern Africa. AIDS. 2008;22(Suppl 4):S5-S16.
25. Hallett TB, White PJ, Garnett GP. Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation. Sex Transm Infect. 2007;83;55-60.
26. Hallett TB, Aberle-Grasse J, Bello G, et al. Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti. Sex Transm Infect. 2006;82(Suppl I):i1-i8.
27. Stoneburner RL, Low-Beer D. Population-Level HIV declines and behavioral risk avoidance in Uganda. Science. 2004;304:714-718. (Pubitemid 38560873)
28. Gregson S, Garnett GP, Nyamukapa CA, et al. HIV decline associated with behavior change in Eastern Zimbabwe. Science. 2006;211:664-666. (Pubitemid 43191311)
29. Mahomva A, Greby S, Dube S, et al. HIV prevalence and trends from data in Zimbabwe, 1997-2004. Sex Transm Infect. 2006;82(Suppl 1):i42-i47.
30. Mbulaiteye S, Mahe C, Whitworth J, et al. Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study. Lancet. 2002;360:41-46. (Pubitemid 34756491)
31. Parkhurst J. "What worked?": the evidence, challenges in determining the causes of HIV prevalence decline. AIDS Educ Prev. 2008;20:275-283.
32. Kirby D. Changes in sexual behaviour leading to the decline in the prevalence of HIV in Uganda: confirmation from multiple sources of evidence. Sex Transm Infect. 2008;84:ii35-ii41.
33. Nelson KE, Celentano DD, Eiumtrakol S, et al. Changes in sexual behaviour and a decline in HIV infection among young men in Thailand. N Engl J Med. 1996;86:1713-1716.
34. Rajanapithayakorn W, Hanenberg R. The 100% condom program in Thailand. AIDS. 1996;10:1-7. (Pubitemid 26016396)
35. Ly Penh. Proxy indicator for HIV incidence measure. Presented at: 2nd Global HIV/AIDS Surveillance Meeting; March 5, 2009; Bangkok, Thailand.
36. Saliuk T, Varetska O, Skoropatska Y, et al. First indications of impact of prevention programs among injecting drug users on the HIV epidemic in Ukraine: results based on data triangulation from different sources. Presented at: 2nd Global HIV/AIDS Surveillance Meeting; March 5, 2009; Bangkok, Thailand.
37. Plipat T, Naiwatanakul T, Rattanasuporn N, et al. Reduction in motherto-child transmission of HIV in Thailand, 2001-2003: results from population-based surveillance in six provinces. AIDS. 2007;21:145-151. (Pubitemid 46036921)
38. Paintsil E, Andiman WA. Update on successes and challenges regarding mother-to-child transmission of HIV. Curr Opin Pediatr. 2009;21(1): 94-101.
39. Jahn A, Floyd S, Crampin AC, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008;371:1603-1611. (Pubitemid 351626844)
40. Reniers G, Araya T, Davey G, et al. Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia. AIDS. 2009;23:511-518.
41. Dorrington R, Bourne D, Bradshaw D, et al. The impact of HIV/AIDS on adult mortality in South Africa. 2001 September. Medical Research Council. Available at: http://www.mrc.ac.za/bod/. Accessed October 2, 2009.
42. Anderson BA, Phillips HE. Adult Mortality (Age 15-64) Based on Death Notification Data in South Africa: 1997-2004. Report No. 03-09-05. Pretoria, South Africa: Statistics South Africa; Actuarial Society of South Africa; 2005.
43. Medical Research Council. South African national burden of disease study 2000. Cape Town, South Africa:Medical Research Council; 2005. Available at: http://www.mrc.ac.za/bod/estimates.htm. Accessed October 2, 2009.
44. Bradshaw D, Laubscher R, Dorrington R, et al. Unabated rise in number of adult deaths in South Africa. S Afr Med J. 2004;94:278-279. (Pubitemid 38585220)
45. Smith A. Vital registration in South Africa. Presented at: 2nd Global HIV/AIDS Surveillance Meeting; March 4, 2009; Bangkok, Thailand.
46. Mazive E. Mozambique: Post-Census Mortality Survey. Presented at: 2nd Global HIV/AIDS Surveillance Meeting; March 4, 2009; Bangkok, Thailand.
47. Central Statistical Office Zambia. Sample Vital Registration with Verbal Autopsy. Presented at: 2nd Global HIV/AIDS Surveillance Meeting, March 4, 2009; Bangkok, Thailand. (presented by Lorraine West).